Choroidal Reflectance Camera for the Detection of Congenital Cataracts

Sponsor
Cambridge University Hospitals NHS Foundation Trust (Other)
Overall Status
Unknown status
CT.gov ID
NCT03035292
Collaborator
(none)
260
1
10
26.1

Study Details

Study Description

Brief Summary

Sensitivity and specificity of current screening methods for congenital cataracts in neonates is poor. This results in delayed diagnosis and management which can decrease the visual prognosis following cataract surgery. It also results in many false positives with resultant unnecessary healthcare costs in specialist paediatric ophthalmology services. The investigator has developed a new digital technique to improve the accuracy of screening for congenital cataract and this study will compare this new test with the current test performed.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    All babies born in the United Kingdom undergo eye screening at birth and 6-8 weeks to enable the early diagnosis and management of congenital cataract, a treatable but potentially blinding condition affecting 1 in 2000 newborns. The current technique involves the assessment of the "red reflex" - the orange/red glow in the pupil seen during ophthalmoscopy (or flash photography) due to reflectance of light from the back of the eye. In reality, testing can be technically difficult because the pupil constricts to light during the examination and , particularly in babies of Asian and Afro-Caribbean ancestry, the red-reflex can be dim due to the effect of ocular pigmentation. As a result less than 50% of congenital cataracts are currently identified up by screening. Early visual experience is required for good visual development and a delay in the surgical management of cataracts results in sub-optimal visual development and visual impairment.

    The neonatal congenital cataract screening tests are performed by a range of healthcare professionals including nurses, midwives and doctors.

    The investigators have developed a new digital camera imaging system based on a modified mobile phone which improves the detection of choroidal reflectance, improving the pick up rate of cataract and other congenital eye malformations and allowing documentation of the examination and telemedicine of the digital image. The investigators predict that this will facilitate screening and improve the early detection and management of congenital cataract worldwide.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    260 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Proof of Concept Trial of a Novel Imaging System to Assess and Document Choroidal Reflectance in Infants for the Detection of Cataract and Media Opacities.
    Actual Study Start Date :
    Feb 1, 2017
    Anticipated Primary Completion Date :
    Aug 1, 2017
    Anticipated Study Completion Date :
    Dec 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Test of diagnostic sensitivity [8 months]

      Comparison of the sensitivity (true positive rate) of diagnosis of congenital cataract using the choroidal reflectance camera compared to current method with reference to a gold standard examination

    2. Test of diagnostic specificity [8 months]

      Comparison of the specificity (true negative rate) of diagnosis of congenital cataract using the choroidal reflectance camera compared to current method with reference to a gold standard examination

    Secondary Outcome Measures

    1. Comparison of ease of use in differing ethnic groups [8 months]

      Comparison of difficulty of assessment using a questionnaire completed by the examiner with reference to ethnic group

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All newborns having NIPE screening.

    • All children under 5 years of age attending paediatric ophthalmology clinic

    Exclusion Criteria:
    • Parents / carers with poor conversant English

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Addenbrooke's Hospital Cambridge Cambridgeshire United Kingdom CB2 0QQ

    Sponsors and Collaborators

    • Cambridge University Hospitals NHS Foundation Trust

    Investigators

    • Principal Investigator: Louise E Allen, MBBS MD, Cambridge University Hospitals NHS Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr Louise Allen, Consultant Paediatric Ophthalmologist, Cambridge University Hospitals NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT03035292
    Other Study ID Numbers:
    • 159569
    • REC17/EE/0010
    First Posted:
    Jan 30, 2017
    Last Update Posted:
    Jun 27, 2017
    Last Verified:
    Jun 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 27, 2017